Concepedia

Milad Soleimani

MS

5

Publications

127

Citations

5

H-Index

2007

Active since

Affiliations

The University of Texas at Austin(Current)

University of Colorado Cancer Center

University of Colorado Anschutz Medical Campus

Livestrong Foundation

University of Colorado Denver

Milad Soleimani is an author at The University of Texas at Austin specializing in tumor biology, cancer research, and cancer cell biology.

ORCID

Top concepts

Publications per year

2007–2023

5

Publications

5

Nanofibrous Poly(ε-Caprolactone)/Poly(Vinyl Alcohol)/Chitosan Hybrid Scaffolds for Bone Tissue Engineering using Mesenchymal Stem Cells

Yousef Mohammadi, Milad Soleimani, Mohammad Fallahi‐Sichani et al. · The International Journal of Artificial Organs · 2007 · 77 citations

Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and Autophagy

Milad Soleimani, Alexander Somma, Tamer S. Kaoud et al. · Molecular Cancer Therapeutics · 2022 · 17 citations

, , +20

Comparative process-based life-cycle assessment of bioconcrete and conventional concrete

Milad Soleimani, Mohsen Shahandashti · Journal of Engineering Design and Technology · 2017 · 13 citations

, , +12

Dual compartmental targeting of cell cycle and angiogenic kinases in colorectal cancer models

Anna Capasso, Todd M. Pitts, Peter J. Klauck et al. · Anti-Cancer Drugs · 2018 · 10 citations · Full text

, , +17

Elucidating the direct effects of the novel HDAC inhibitor bocodepsin (OKI-179) on T cells to rationally design regimens for combining with immunotherapy

Nisha Holay, Alexander Somma, Mark Duchow et al. · Frontiers in Immunology · 2023 · 10 citations · Full text

Rows per page

1–5 of 5